Dr. Scott Gottlieb on CAR-T therapies, Pres. Trump's psychedelics EO and FDA approval process

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of Eli Lilly in advance talks to acquire ...
American Enterprise Institute

Discussing GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box.” ...
American Enterprise Institute

Discussing the rapid expansion of CAR-T therapies and efforts to streamline FDA approvals for next-gen treatments: Gottlieb on CNBC’s ‘Sqauwk Box’

Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments ...
American Enterprise Institute

Discussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...